Clinical Trial Result Information

Protocol number
WA17531

Title of Study
A Study to Assess the Safety and Efficacy of Retreatment with MabThera (rituximab) in Patients with Rheumatoid Arthritis Who Have Failed on anti-TNFα Therapy

Sponsor
Roche Products Ltd / IDEC Pharmaceuticals Corporation

Company division
Pharmaceutical

Product name
MabThera/Rituxan

Generic name
rituximab

Therapeutic area
Rheumatoid arthritis

Clinical study summary
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Phase of development
III

Date of report
To be Published

Click here for the protocol registry listing of this trial.